Related Experiment Video
Updated: Oct 25, 2025

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
Published on: March 30, 2018
Mesenchymal Stem Cells: From Regeneration to Drug Delivery Systems
Zeeshan Shokat1, Abdaal Ali1, Uzair Ahmed2
1Department of Bioinformatics and Biotechnology, Government College University, Faisalabad (GCUF), Allama Iqbal Road, Faisalabad-38000, Pakistan.
Abstract:
Targeting drug delivery has been a focus of researchers in recent years for cancer and other diseases. Many approaches such as liposomes, exosomes, nanoparticles (magnetic), encapsulation etc. have been developed and investigated for their clinical applications. But disadvantages linked to these therapies limit them to be used in clinical settings. Cell based drug delivery systems has emerged as an alternative for these therapies. Among cell types, mesenchymal stem cells (MSCs) proved to a potential cell type for research due to its many characteristics including low immunogenicity, chemotaxis and homing to tumor sites which are considered mandatory for drug delivery. This chapter focuses on the challenges and opportunities in using MSCs as therapeutic carrier of drugs in different ailments.
Insights
Mesenchymal stem cells (MSCs) offer a promising cell-based alternative for targeted drug delivery, overcoming limitations of traditional methods. This research explores MSCs
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Oncology
Background:
- Targeted drug delivery is crucial for treating cancer and other diseases.
- Existing methods like liposomes and nanoparticles have limitations for clinical use.
- Cell-based drug delivery systems present a novel therapeutic alternative.
Purpose of the Study:
- To explore the potential of mesenchymal stem cells (MSCs) as drug delivery vehicles.
- To discuss the challenges and opportunities associated with using MSCs for therapeutic drug delivery.
- To highlight MSCs' unique properties for targeted delivery applications.
Main Methods:
- Review of existing literature on cell-based drug delivery systems.
- Analysis of mesenchymal stem cells' characteristics relevant to drug delivery.
- Identification of challenges and opportunities in MSC-mediated drug delivery.
Main Results:
- Mesenchymal stem cells (MSCs) possess key characteristics for drug delivery, including low immunogenicity and tumor-homing abilities.
- MSCs can be engineered to carry and deliver therapeutic agents to specific sites.
- Challenges remain in optimizing MSC-based delivery for widespread clinical application.
Conclusions:
- Mesenchymal stem cells (MSCs) represent a viable and advantageous platform for targeted drug delivery.
- Further research and development are needed to overcome challenges and fully realize the clinical potential of MSC-based therapies.
- MSCs offer a promising future for enhanced therapeutic efficacy and reduced side effects in various ailments.
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Stem Cell Culture
Tissue Renewal without Stem Cells
However, failure of such a system...
Embryonic Stem Cells
iPS Cell Differentiation

